Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report “Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Taiwan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Taiwan’s healthcare system is emerging as one of the most advanced healthcare systems in Asia, with government policies supporting the biomedical sector and digital health. The pharmaceutical market of Taiwan, based on domestic production (excluding imports), was valued at $2.4 billion in 2015 and increased at a Compound Annual Growth Rate (CAGR) of 3.2% to reach $2.7 billion in 2018. The market is expected to grow further at a CAGR of 3.2% to reach $3.4 billion in 2026. Taiwan’s medical devices market was valued at $2.2 billion in 2016, which increased at a CAGR of 4.2% to reach $2.7 billion in 2021. In May 2022, Hong Kong-based IntelliCentrics signed a memorandum of Understanding (MoU) with Taiwan Life Insurance Company to provide Taiwanese individuals with remote access to high-quality healthcare services and physicians while in Taiwan or traveling abroad. IntelliCentrics will deliver services in Taiwan using EU Care. IntelliCentrics and Taiwan Life plan to begin the program after examining mutual advantages and securing permissions.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Taiwan, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Sanofi, Merck, GSK, and CCPC.
• Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Medtronic, Stryker, Depuy Synthes, and TaiDoc.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Taiwan healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving Taiwan healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Taiwan healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership